JAMA Psychiatry
Coverage of JAMA Psychiatry in the Nexus archive.
- Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression
A study examines the efficacy and safety of psilocybin in treating major depression that has not responded to conventional treatments. The research focuses on its potential as a therapeutic intervention for this specific mental health condition.
- Single infusion of controversial drug changed severe depression symptoms within hours, study finds
A study reviewed 26 clinical trials involving over 1,100 patients, finding that a single ketamine infusion significantly reduced severe depression symptoms within four hours and lowered suicidal thoughts within 24 hours. The analysis suggests ketamine may offer rapid relief for treatment-resistant depression, though it carries risks like dissociation and nausea.
- 'How are you using AI?' Your therapist should ask you that question, experts argue
A JAMA Psychiatry paper recommends mental health providers should inquire about patients' use of AI chatbots, similar to assessing sleep habits and substance use. Experts argue this could improve mental health care by addressing potential impacts of AI on patient well-being.